Patents by Inventor Axel Prox

Axel Prox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Highly concentrated stable meloxicam solutions
    Patent number: 9993557
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: June 12, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Jurgen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • Highly concentrated stable meloxicam solutions
    Patent number: 9956288
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The solution is for treating a mammal suffering from one or more of pain, inflammation, fever, acute mastitis, diarrhea, lameness, locomotor deficiency, or respiratory illness.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: May 1, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS
    Publication number: 20170035885
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The solution is for treating a mammal suffering from one or more of pain, inflammation, fever, acute mastitis, diarrhea, lameness, locomotor deficiency, or respiratory illness.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 9, 2017
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS
    Publication number: 20130178467
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: March 14, 2013
    Publication date: July 11, 2013
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • Highly concentrated stable meloxicam solutions
    Publication number: 20060079516
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: November 30, 2005
    Publication date: April 13, 2006
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin Folger, Klaus Daneck, Axel Prox
  • Highly concentrated stable meloxicam solutions
    Publication number: 20020035107
    Abstract: Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being more than 10 mg/mL. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: May 18, 2001
    Publication date: March 21, 2002
    Inventors: Stefan Henke, Bernd Kruss, Bernhard Hassel, Hans-Juergen Kroff, Martin A. Folger, Klaus Daneck, Axel Prox
  • 6-Hydroxy-2-phenyl-imidazo[4,5-b]pyridines and salts thereof
    Patent number: 4353909
    Abstract: Compounds of the formula ##STR1## wherein R is methylsulfinyl or methylsulfonyl, their 3H-tautomers, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds are useful as cardiotonics.
    Type: Grant
    Filed: September 24, 1981
    Date of Patent: October 12, 1982
    Assignee: Dr. Karl Thomae Gesellschaft mit beschrankter Haftung
    Inventors: Willi Diederen, Axel Prox, Albert Reuter, Willy Roth, Jochen Schmid